Syngene International Ltd Stock Price Today (NSE: SYNGENE)
Syngene International Ltd
Fundamental Score
Syngene International Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Syngene International Ltd share price today is ₹448.30, down 1.06% on NSE/BSE as of 17 June 2026. Syngene International Ltd (SYNGENE) is a Large-cap company in the Healthcare Research, Analytics & Technology sector with a market capitalisation of ₹25.99K (Cr). The 52-week high for SYNGENE share price is ₹728.60 and the 52-week low is ₹380.00. At a P/E ratio of 55.50x, SYNGENE is currently trading above its industry average P/E of 45.95x. The company has a Return on Equity (ROE) of 10.53% and a debt-to-equity ratio of 0.12.
Syngene International Ltd Share Price Chart — NSE/BSE Historical Performance
Syngene International Ltd share price chart: 5.13% return over the past month. 52-week high ₹728.60, 52-week low ₹380.00.
Syngene International Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹444.05 | ₹447.55 | ₹435.85 | ₹440.85 | 5.18L (Cr) | |
| ₹443.00 | ₹451.35 | ₹439.35 | ₹448.00 | 6.42L (Cr) | |
| ₹460.40 | ₹464.15 | ₹436.05 | ₹442.00 | 9.42L (Cr) | |
| ₹460.40 | ₹460.40 | ₹460.40 | ₹460.40 | 0.00 (Cr) | |
| ₹467.90 | ₹467.90 | ₹459.00 | ₹460.40 | 12.79L (Cr) | |
| ₹463.00 | ₹472.75 | ₹463.00 | ₹465.25 | 3.83L (Cr) | |
| ₹467.00 | ₹472.00 | ₹458.45 | ₹462.40 | 8.78L (Cr) | |
| ₹471.95 | ₹472.15 | ₹460.25 | ₹461.85 | 4.77L (Cr) | |
| ₹473.00 | ₹473.80 | ₹464.35 | ₹470.20 | 3.70L (Cr) | |
| ₹471.10 | ₹475.20 | ₹461.75 | ₹466.05 | 6.15L (Cr) |
Syngene International Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹443.00 | ₹451.35 | ₹435.85 | ₹440.85 | -0.49% | |
| ₹467.35 | ₹492.25 | ₹436.05 | ₹442.00 | -5.42% | |
| ₹395.05 | ₹518.55 | ₹380.00 | ₹467.65 | +18.38% | |
| ₹413.15 | ₹428.00 | ₹387.05 | ₹389.90 | -5.63% | |
| ₹467.10 | ₹512.95 | ₹418.10 | ₹422.20 | -9.61% | |
| ₹650.05 | ₹678.95 | ₹467.70 | ₹473.45 | -27.17% | |
| ₹651.50 | ₹665.30 | ₹623.65 | ₹651.00 | -0.08% | |
| ₹654.55 | ₹673.40 | ₹608.60 | ₹648.30 | -0.95% | |
| ₹623.30 | ₹667.85 | ₹617.55 | ₹650.10 | +4.30% | |
| ₹622.10 | ₹673.90 | ₹607.05 | ₹622.85 | +0.12% | |
| ₹714.00 | ₹714.35 | ₹624.60 | ₹625.90 | -12.34% | |
| ₹638.90 | ₹728.60 | ₹620.70 | ₹714.00 | +11.75% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Syngene International Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Syngene International Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SYNGENE across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Operating Margins (29.64%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Consistent Growth Track Record (12.60% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Conservative Debt Levels (D/E: 0.12)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (12.45x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹1615.90 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (52.68%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Strong Institutional Confidence (FII+DII: 40.93%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Premium Valuation Risk (P/E: 55.50x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-36.76%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Syngene International Ltd vs Healthcare Research, Analytics & Technology Peers
Peer Comparison - Healthcare Research, Analytics & Technology
Compare Syngene International Ltd with 8 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Syngene International LtdSyngene Interna...Selected✓ SYNGENE • 539268 | 41.6/100 | ₹448.30₹448 | ₹25985.68₹25985.68 | 55.50Average 55.5 Average | 10.53%Average 10.53% Average | 13.52%Average 13.52% Average | 0.12Excellent 0.1 Excellent | 5.71%Good 5.71% Good | 12.60%Good 12.60% Good | 0.19% |
Indegene LtdIndegene Ltd... INDGN • 544172 | 66.8/100 | ₹511.40₹511 | ₹12660.10₹12660.10 | 28.40Average 28.4 Average | 20.59%Excellent 20.59% Excellent | 24.80%Excellent 24.80% Excellent | 0.04Excellent 0.0 Excellent | 67.93%Excellent 67.93% Excellent | 34.59%Excellent 34.59% Excellent | 0.38% |
Suven Life Sciences LtdSuven Life Scie... SUVEN • 530239 | 6.5/100 | ₹269.43₹269 | ₹3927.58₹3927.58 | — — | -87.22%Poor -87.22% Poor | -86.96%Poor -86.96% Poor | 0.00Excellent 0.0 Excellent | -24.19%Poor -24.19% Poor | -12.00%Poor -12.00% Poor | 0.00% |
Vimta Labs LtdVimta Labs Ltd... VIMTALABS • 524394 | 65.8/100 | ₹453.10₹453 | ₹2716.50₹2716.50 | 36.39Average 36.4 Average | 19.43%Good 19.43% Good | 25.22%Excellent 25.22% Excellent | 0.02Excellent 0.0 Excellent | 58.03%Excellent 58.03% Excellent | 13.74%Good 13.74% Good | 0.16% |
Take Solutions LtdTake Solutions ... TAKE • 532890 | 19.5/100 | ₹25.53₹26 | ₹481.24₹481.24 | 120.61Average 120.6 Average | 644.12%Excellent 644.12% Excellent | 11.24%Average 11.24% Average | 0.00Excellent 0.0 Excellent | 38.14%Excellent 38.14% Excellent | — — | 0.00% |
Bilcare LtdBilcare Ltd... BI • 526853 | 6.9/100 | ₹62.20₹62 | ₹200.42₹200.42 | — — | -5.58%Poor -5.58% Poor | 1.10%Poor 1.10% Poor | 1.48Average 1.5 Average | 13.81%Good 13.81% Good | -15.48%Poor -15.48% Poor | 0.00% |
NOVELIX PHARMACEUTICALS LIMITENOVELIX PHARMAC... NOVELIX • 536565 | 40.6/100 | ₹54.00₹54 | ₹101.70₹101.70 | 104.85Average 104.8 Average | 0.64%Poor 0.64% Poor | 0.96%Poor 0.96% Poor | 0.00Excellent 0.0 Excellent | -2.33%Poor -2.33% Poor | 82.92%Excellent 82.92% Excellent | 0.00% |
Adeshwar Meditex LtdAdeshwar Medite... ADESHWAR • 543309 | 29.2/100 | ₹18.41₹18 | ₹25.54₹25.54 | 12.34Average 12.3 Average | 5.51%Poor 5.51% Poor | 8.27%Poor 8.27% Poor | 0.16Excellent 0.2 Excellent | -1.36%Poor -1.36% Poor | 8.33%Good 8.33% Good | 0.00% |
Vanta Bioscience LtdVanta Bioscienc... VANTABIO • 540729 | 7.2/100 | ₹24.45₹24 | ₹16.84₹16.84 | — — | -37.24%Poor -37.24% Poor | -11.58%Poor -11.58% Poor | 1.59Average 1.6 Average | — — | -32.27%Poor -32.27% Poor | 0.00% |
Top Healthcare Research, Analytics & Technology Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Indegene Ltd share price12660.10 Cr
- Suven Life Sciences Ltd share price3927.58 Cr
- Vimta Labs Ltd share price2716.50 Cr
- Take Solutions Ltd share price481.24 Cr
- Bilcare Ltd share price200.42 Cr
Syngene International Ltd PE Ratio History
Historical price-to-earnings ratio for SYNGENE — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹12.34 | ₹651.00 | 52.8x |
| FY 2024 | ₹12.69 | ₹858.45 | 67.6x |
| FY 2023 | ₹11.51 | ₹701.45 | 60.9x |
| FY 2022 | ₹9.82 | ₹585.55 | 59.6x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Syngene International Ltd Dividend History
Annual cash dividends paid by SYNGENE — dividend yield 0.19%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹50.30 Cr |
| FY 2024 | ₹50.30 Cr |
| FY 2023 | ₹40.10 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Syngene International Ltd Quarterly Performance
Latest quarterly metrics for SYNGENE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
2.20%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-36.76%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
12.60%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
5.71%
Compounded annual net profit growth over 5 years
Syngene International Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SYNGENE — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Syngene International Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Syngene International Ltd (SYNGENE) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Syngene International Ltd
About SYNGENE (Syngene International Ltd)
Syngene International Ltd (SYNGENE) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Healthcare Research, Analyt...ics & Technology sector with a current market capitalisation of ₹25.99K (Cr). Syngene International Ltd has delivered a Return on Equity (ROE) of 10.53% and a ROCE of 13.52%. The debt-to-equity ratio stands at 0.12, reflecting the company's capital structure. Investors tracking SYNGENE share price can monitor key metrics including P/E ratio, promoter holding of 52.68%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
Latest News
SYNGENE Share Price: Frequently Asked Questions
What is the current share price of Syngene International Ltd?
Syngene International Ltd (SYNGENE) trades at ₹448.30 on NSE and BSE. Market cap ₹25.99K (Cr). Educational data only.
What is the P/E ratio of Syngene International Ltd?
Syngene International Ltd has a P/E of 55.50x vs industry average 45.95x.
What is the Bull Run score for Syngene International Ltd?
Syngene International Ltd has a Bull Run score of 41.6/100 based on 25+ financial parameters.
Does Syngene International Ltd pay dividends?
Syngene International Ltd has a dividend yield of 0.19%. Past dividends don't guarantee future payments.
What is the ROE of Syngene International Ltd?
Syngene International Ltd has ROE of 10.53%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Syngene International Ltd?
Syngene International Ltd has debt-to-equity of 0.12.
Is Syngene International Ltd a good investment?
Bull Run gives Syngene International Ltd a score of 41.6/100. This is not investment advice — consult a SEBI-registered advisor.